Brevan Howard Capital Management’s Idexx Laboratories IDXX Stock Holding History

Brevan Howard Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.58M	Buy	+10,606	New	+$5.95M	0.04%	301
2025 Q4	–	Sell	-3,030	Closed	-$1.94M	–	2034
2025 Q3	$1.94M	Sell	3,030 -5,636	-65%	-$3.42M	0.01%	578
2025 Q2	$4.65M	Buy	+8,666	New	+$4.14M	0.03%	384
2025 Q1	–	Sell	-8,513	Closed	-$3.52M	–	1297
2024 Q4	$3.52M	Buy	8,513 +7,872	+1,228%	+$3.45M	0.02%	189
2024 Q3	$324K	Buy	+641	New	+$311K	﹤0.01%	822
2024 Q2	–	Sell	-775	Closed	-$418K	–	1200
2024 Q1	$418K	Sell	775 -4,960	-86%	-$2.71M	﹤0.01%	515
2023 Q4	$3.18M	Buy	+5,735	New	+$2.69M	0.04%	70

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Brevan Howard Capital Management's IDXX Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 10,606 shares worth $5.58M. The stake represents 0.04% of the portfolio and ranks #301 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in IDXX as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in IDXX in Q4 2023 and has held it in 7 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Brevan Howard Capital Management held 10,606 shares of Idexx Laboratories worth $5.58M as of Q2 2026.
Idexx Laboratories was a new Brevan Howard Capital Management position in Q2 2026.
Idexx Laboratories made up 0.04% of Brevan Howard Capital Management's portfolio in Q2 2026, its #301 holding.
Brevan Howard Capital Management first reported a position in Idexx Laboratories in Q4 2023 and has held it in 7 quarters since.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.